Targeted Therapy Drugs Slow the Growth and Spread of Advanced Non-Small Cell Lung Cancer

Two studies showed that treatment with targeted therapy drugs (drugs that target the faulty genes and proteins that contribute to cancer growth) slowed the growth and spread of advanced NSCLC. These studies include:

• Adding the drug erlotinib (Tarceva) to follow-up treatment with the drug bevacizumab (Avastin)
• Adding the drug vandetanib (Zactima) to standard chemotherapy with docetaxel (Taxotere)

For More Information

Cancer.Net Guide to Lung Cancer

ASCO Answers Fact Sheet: Lung Cancer

ASCO Expert Corner: A Decision Aid Tool for Lung Cancer

Lung Cancer Treatment Plans and Summaries

Understanding Targeted Treatments